Association between regulatory T cell activity and sepsis and outcome of severely burned patients: A prospective, observational study

Critical Care

Volumn 14, Issue 1, 2010, Pages

  Huang, Li feng ^a   Yao, Yong ming ^a   Dong, Ning ^a   Yu, Yan ^a   He, Li xin ^a   Sheng, Zhi yong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FORKHEAD TRANSCRIPTION FACTOR; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1; PRIMER DNA;

ADULT; ARTICLE; BLOOD SAMPLING; BURN; BURN PATIENT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SEPSIS; SURVIVAL; BLOOD; HOSPITALIZATION; IMMUNOLOGY; IMMUNOPHENOTYPING; NUCLEOTIDE SEQUENCE; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BASE SEQUENCE; BURNS; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-10; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77649286748     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8232     Document Type: Article

References (42)

1. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562.
2. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001, 182:68-79.
3. Zhai Y, Kupiec-Weglinski JW. What is the role of regulatory T cells in transplantation tolerance?. Curr Opin Immunol 1999, 11:497-503.
4. Shevach EM. CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002, 2:389-400.
5. Ramsdell F. Foxp3 and natural regulatory T cells: key to a cell lineage?. Immunity 2003, 19:165-168.
6. Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, Hartgers FC, Elferink BG, Zanden L, de Vries RR, Huizinga TW, Ottenhoff TH, Toes RE. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 2005, 66:13-20.
7. Finnerty CC, Herndon DN, Przkora R, Pereira CT, Oliveira HM, Queiroz DM, Rocha AM, Jeschke MG. Cytokine expression profile over time in severely burned pediatric patients. Shock 2006, 26:13-19.
8. O'Garra A, Vieira PL, Vieira P, Goldfeld AE. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 2004, 114:1372-1378. 525746, 15545984.
9. Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, Poitevin F, Bohé J, Lepape A, Ayala A, Monneret G. Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 2009, 35:678-686.
10. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005, 6:353-360.
11. Efron P, Moldawer LL. Sepsis and the dendritic cell. Shock 2003, 20:386-401.
12. Peden M, McGee K, Sharma G. The injury chart book: a graphical overview of the global burden of injuries. 2002, 29. Geneva: World Health Organization.
13. Pereira CT, Barrow RE, Sterns AM, Hawkins HK, Kimbrough CW, Jeschke MG, Lee JO, Sanford AP, Herndon DN. Age-dependent differences in survival after severe burns: a unicentric review of 1,674 patients and 179 autopsies over 15 years. J Am Coll Surg 2006, 202:536-548.
14. Mannick JA, Rodrick ML, Lederer JA. The immunologic response to injury. J Am Coll Surg 2001, 193:237-244.
15. Shelley OT, Murphy H, Paterson JA, Mannick JA. Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury. Shock 2003, 20:123.
16. Roncarolo MG, Gregori S, Levings M. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells. Novartis Found Symp 2003, 252:115-127. discussion 127-131, 203-210.
17. Yende S, Kellum JA. Understanding genetics of sepsis: will new technology help?. Crit Care 2009, 13:141.
18. Venet F, Bohé J, Debard AL, Bienvenu J, Lepape A, Monneret G. Both percentage of gammadelta T lymphocytes and CD3 expression are reduced during septic shock. Crit Care Med 2005, 33:2836-2840.
19. O'Brien JM, Ali NA, Abraham E. Year in review 2007: Critical Care--multiple organ failure and sepsis. Crit Care 2008, 12:228. 2592721, 18983708.
20. Greenhalgh DG, Saffle JR, Holmes JH, Gamelli RL, Palmieri TL, Horton JW, Tompkins RG, Traber DL, Mozingo DW, Deitch EA, Goodwin CW, Herndon DN, Gallagher JJ, Sanford AP, Jeng JC, Ahrenholz DH, Neely AN, O'Mara MS, Wolf SE, Purdue GF, Garner WL, Yowler CJ, Latenser BA. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res 2007, 28:776-790.
21. Kurokawa CS, Araujo JP, Soares AM, Sugizaki MF, Peraçoli MT. Pro- and anti-inflammatory cytokines produced by human monocytes challenged in vitro with Paracoccidioides brasiliensis. Microbiol Immunol 2007, 51:421-428.
22. Rostkowska-Nadolska B, Kapral M, Mazurek U, Gawron W, Preś K. Co-expression of the TGF-beta1 and TGF- beta2 isoforms in nasal polyps and in healthy mucosa. Postepy Hig Med Dosw (Online) 2007, 61:702-707.
23. Lyng MB, Laenkholm AV, Pallisgaard N, Ditzel HJ. Identification of genes for normali zation of real-time RT-PCR data in breast carcinomas. BMC Cancer 2008, 8:20. 2248196, 18211679.
24. Guo Z, Kavanagh E, Zang Y, Dolan SM, Kriynovich SJ, Mannick JA, Lederer JA. Burn Injury promotes antigen-driven Th2-type responses in vivo. J Immunol 2003, 171:3983-3990.
25. Zhang LT, Yao YM, Lu JQ, Yan XJ, Yu Y, Sheng ZY. Recombinant bactericidal/permeability- increasing protein inhibits endotoxin-induced high-mobility group box 1 protein gene expression in sepsis. Shock 2008, 29:278-284.
26. Huang LF, Yao YM, Meng HD, Zhao XD, Dong N, Yu Y, Sheng ZY. The effect of high mobility group box-1 protein on immune function of human T lymphocytes in vitro. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2008, 20:7-13.
27. Schneider DF, Glenn CH, Faunce DE. Innate lymphocyte subsets and their immunoregulatory roles in burn injury and sepsis. J Burn Care Res 2007, 28:365-379.
28. MacConmara MP, Maung AA, Fujimi S, McKenna AM, Delisle A, Lapchak PH, Rogers S, Lederer JA, Mannick JA. Increased CD4+ CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg 2006, 244:514-523. 1856576, 16998360.
29. Zhang LT, Yao YM, Dong Ning Dong YQ, Yu Y, Sheng ZY. Relationship between high mobility group box-1 protein release and T cell suppression in rats after thermal injury. Shock 2008, 30:449-455.
30. Murphy TJ, Ni Choileain N, Zang Y, Mannick JA, Lederer JA. CD4+CD25+ regulatory T cells control innate immune reactivity after injury. J Immunol 2005, 174:2957-2963.
31. Huang LF, Yao YM, Zhang LT, Dong N, Yu Y, Sheng ZY. The effect of high mobility group box-1 protein on activity of regulatory T cells after thermal injury in rats. Shock 2009, 31:322-329.
32. Walsh DS, Siritongtaworn P, Pattanapanyasat K, Thavichaigarn P, Kongcharoen P, Jiarakul N, Tongtawe P, Yongvanitchit K, Komoltri C, Dheeradhada C, Pearce FC, Wiesmann WP, Webster HK. Lymphocyte activation after non-thermal trauma. Br J Surg 2000, 87:223-230.
33. Ni Choileain N, MacConmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA. Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol 2006, 176:225-236.
34. Marie JC, Letterio JJ, Gavin M, Rudensky AY. TGF-β 1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 2005, 201:1061-1067. 2213134, 15809351.
35. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004, 22:929-979.
36. Zhang Y, Yao YM, Yu Y, Wu Y, Sheng ZY. Influence of high mobility group box-1 protein on the correlation between regulatory T cells and CD4+ CD25- T cells of spleen in mice. Zhonghua Wai Ke Za Zhi 2008, 46:217-220.
37. Monneret G, Debard AL, Venet F, Bohe J, Hequet O, Bienvenu J, Lepape A. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 2003, 31:2068-2071.
38. Dong N, Yao YM, Cao YJ, He LX, Chai JK, Xu S, Sheng ZY. Clinical significance of changes in quantitative expression of human leukocyte antigen DR in severely burned patients. Zhonghua Wai Ke Za Zhi 2007, 45:766-769.
39. Venet F, Tissot S, Debard AL, Faudot C, Crampé C, Pachot A, Ayala A, Monneret G. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock. Crit Care Med 2007, 35:1910-1917.
40. Dong N, Yao YM, Cao YJ, He LX, Yu Y, Chai JK, Sheng ZY. The clinical significance of changes in immunological function of T lymphocyte in severe burn patients with sepsis. Zhonghua Shao Shang Za Zhi 2007, 23:84-87.
41. Venet F, Chung CS, Monneret G, Huang X, Horner B, Garber M, Ayala A. Regulatory T cell populations in sepsis and trauma. J Leukoc Biol 2008, 83:523-535.
42. Wisnoski N, Chung CS, Chen Y, Huang X, Ayala A. The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis. Shock 2007, 27:251-257. 1805637, 17304105.